AAAAAA

   
Results: 1-24 |
Results: 24
CELLULAR PROVIRAL HIV TYPE-1 DNA LOAD PERSISTS AFTER LONG-TERM RT-INHIBITOR THERAPY IN HIV TYPE-1 INFECTED PERSONS
Authors: BRUISTEN SM REISS P LOELIGER AE VANSWIETEN P SCHUURMAN R BOUCHER CAB WEVERLING GJ HUISMAN JG
Citation: Sm. Bruisten et al., CELLULAR PROVIRAL HIV TYPE-1 DNA LOAD PERSISTS AFTER LONG-TERM RT-INHIBITOR THERAPY IN HIV TYPE-1 INFECTED PERSONS, AIDS research and human retroviruses, 14(12), 1998, pp. 1053-1058
EFFICIENT INHIBITION OF BOTH SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING WILD-TYPE HIV-1 BY LAMIVUDINE IN-VIVO
Authors: WOUT ABVT RAN LJ NIJHUIS M TIJNAGEL JMGH DEGROOT T VANLEEUWEN R BOUCHER CAB SCHUITEMAKER H SCHUURMAN R
Citation: Abvt. Wout et al., EFFICIENT INHIBITION OF BOTH SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING WILD-TYPE HIV-1 BY LAMIVUDINE IN-VIVO, AIDS, 12(10), 1998, pp. 1169-1176
STOCHASTIC-PROCESSES STRONGLY INFLUENCE HIV-1 EVOLUTION DURING SUBOPTIMAL PROTEASE-INHIBITOR THERAPY
Authors: NIJHUIS M BOUCHER CAB SCHIPPER P LEITNER T SCHUURMAN R ALBERT J
Citation: M. Nijhuis et al., STOCHASTIC-PROCESSES STRONGLY INFLUENCE HIV-1 EVOLUTION DURING SUBOPTIMAL PROTEASE-INHIBITOR THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 95(24), 1998, pp. 14441-14446
HOMOLOGOUS RECOMBINATION FOR RAPID PHENOTYPING OF HIV
Authors: NIJHUIS M SCHUURMAN R BOUCHER CAB
Citation: M. Nijhuis et al., HOMOLOGOUS RECOMBINATION FOR RAPID PHENOTYPING OF HIV, Current opinion in infectious diseases, 10(6), 1997, pp. 475-479
STATE-OF-THE-ART OF GENOTYPIC HIV-1 DRUG-RESISTANCE
Authors: SCHUURMAN R
Citation: R. Schuurman, STATE-OF-THE-ART OF GENOTYPIC HIV-1 DRUG-RESISTANCE, Current opinion in infectious diseases, 10(6), 1997, pp. 480-484
IN-VITRO SELECTION OF HIV-1 VARIANTS RESISTANT TO NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS IN MONOCYTE-DERIVED MACROPHAGES
Authors: BEENTIKTAK AMM DEHAAS CJC DEGRAAF L BOUCHER CAB VERHOEF J BORLEFFS JCC NOTTET HSLM SCHUURMAN R
Citation: Amm. Beentiktak et al., IN-VITRO SELECTION OF HIV-1 VARIANTS RESISTANT TO NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS IN MONOCYTE-DERIVED MACROPHAGES, Journal of antimicrobial chemotherapy, 40(6), 1997, pp. 847-853
HIV-1 VIRAL LOAD, PHENOTYPE, AND RESISTANCE IN A SUBSET OF DRUG-NAIVEPARTICIPANTS FROM THE DELTA-TRIAL
Authors: BRUNVEZINET F BOUCHER C LOVEDAY C DESCAMPS D FAUVEAU V IZOPET J JEFFRIES D KAYE S KRZYANOWSKI C NUNN A SCHUURMAN R SEIGNEURIN JM TAMALET C TEDDER R WEBER J WEVERLING GJ ABER V ABOULKER JP BABIKER AG BRAGMAN K BRECKENRIDGE AM CARBON C CHARREAU I CHENE G COLLIS P COOPER D DARBYSHIRE JH DORMONT J FIDDIAN P FLEPP M GAZZARD B GOEBEL FD HOOKER M LANGE J LUTHY R PETO TEA REISS P SELIGMANN M STONE AB THOMIS J VELLA S WALCKENAER G WARRELL D WELLER IVD WILBER R YENI P YEO J WITHNALL R BABIKER A BLOCH J POUCHER C DARBYSHIRE J GOUDSMIT J HURAUX JM VANDERNOORDAA J WEISS R WEVERLING G
Citation: F. Brunvezinet et al., HIV-1 VIRAL LOAD, PHENOTYPE, AND RESISTANCE IN A SUBSET OF DRUG-NAIVEPARTICIPANTS FROM THE DELTA-TRIAL, Lancet, 350(9083), 1997, pp. 983-990
REVERSE-TRANSCRIPTASE FIDELITY AND HIV-1 VARIATION
Authors: KEULEN W NIJHUIS M SCHUURMAN R BERKHOUT B BOUCHER C
Citation: W. Keulen et al., REVERSE-TRANSCRIPTASE FIDELITY AND HIV-1 VARIATION, Science, 275(5297), 1997, pp. 229-229
CLINICAL-DATA SETS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASE-RESISTANT MUTANTS EXPLAINED BY A MATHEMATICAL-MODEL
Authors: STILIANAKIS NI BOUCHER CAB DEJONG MD VANLEEUWEN R SCHUURMAN R DEBOER RJ
Citation: Ni. Stilianakis et al., CLINICAL-DATA SETS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASE-RESISTANT MUTANTS EXPLAINED BY A MATHEMATICAL-MODEL, Journal of virology, 71(1), 1997, pp. 161-168
LAMIVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS (184V) REQUIRE MULTIPLE AMINO-ACID CHANGES TO BECOME CO-RESISTANT TO ZIDOVUDINE IN-VIVO
Authors: NIJHUIS M SCHUURMAN R DEJONG D VANLEEUWEN R LANGE J DANNER S KEULEN W DEGROOT T BOUCHER CAB
Citation: M. Nijhuis et al., LAMIVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS (184V) REQUIRE MULTIPLE AMINO-ACID CHANGES TO BECOME CO-RESISTANT TO ZIDOVUDINE IN-VIVO, The Journal of infectious diseases, 176(2), 1997, pp. 398-405
FIRST CASE OF NEW INFECTION WITH ZIDOVUDINE-RESISTANT HIV-1 AMONG PROSPECTIVELY STUDIED INTRAVENOUS-DRUG-USERS AND HOMOSEXUAL MEN IN AMSTERDAM, THE NETHERLANDS
Authors: DERONDE A SCHUURMAN R GOUDSMIT J VANDENHOEK A BOUCHER C
Citation: A. Deronde et al., FIRST CASE OF NEW INFECTION WITH ZIDOVUDINE-RESISTANT HIV-1 AMONG PROSPECTIVELY STUDIED INTRAVENOUS-DRUG-USERS AND HOMOSEXUAL MEN IN AMSTERDAM, THE NETHERLANDS, AIDS, 10(2), 1996, pp. 231-232
MULTICENTER COMPARISON OF 3 COMMERCIAL METHODS FOR QUANTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA
Authors: SCHUURMAN R DESCAMPS D WEVERLING GJ KAYE S TIJNAGEL J WILLIAMS I VANLEEUWEN R TEDDER R BOUCHER CAB BRUNVEZINET F LOVEDAY C
Citation: R. Schuurman et al., MULTICENTER COMPARISON OF 3 COMMERCIAL METHODS FOR QUANTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA, Journal of clinical microbiology, 34(12), 1996, pp. 3016-3022
HOST-PARASITE DYNAMICS AND OUTGROWTH OF VIRUS CONTAINING A SINGLE K70R AMINO-ACID CHANGE IN REVERSE-TRANSCRIPTASE ARE RESPONSIBLE FOR THE LOSS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LOAD SUPPRESSION BY ZIDOVUDINE
Authors: DEJONG MD VEENSTRA J STILIANAKIS NI SCHUURMAN R LANGE JMA DEBOER RJ BOUCHER CAB
Citation: Md. Dejong et al., HOST-PARASITE DYNAMICS AND OUTGROWTH OF VIRUS CONTAINING A SINGLE K70R AMINO-ACID CHANGE IN REVERSE-TRANSCRIPTASE ARE RESPONSIBLE FOR THE LOSS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LOAD SUPPRESSION BY ZIDOVUDINE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(11), 1996, pp. 5501-5506
RETURN TO BASE-LINE VALUES OF HIV-1 RNA LOAD DURING ZIDOVUDINE TREATMENT IS ASSOCIATED WITH THE EMERGENCE OF K70R MUTANT VIRUS
Authors: DEJONG MD VEENSTRA J STILIANAKIS N SCHUURMAN R DEBOER RJ LANGE JMA BOUCHER CAB
Citation: Md. Dejong et al., RETURN TO BASE-LINE VALUES OF HIV-1 RNA LOAD DURING ZIDOVUDINE TREATMENT IS ASSOCIATED WITH THE EMERGENCE OF K70R MUTANT VIRUS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 20-20
PREFERENTIAL INHIBITION OF NON-SYNCYTIUM-INDUCING HIV-1 VARIANTS BY ZIDOVUDINE
Authors: VANTWOUT AB DEJONG MD KOOTSTRA NA SCHUURMAN R COUTINHO R BOUCHER CAB SCHUITEMAKER H
Citation: Ab. Vantwout et al., PREFERENTIAL INHIBITION OF NON-SYNCYTIUM-INDUCING HIV-1 VARIANTS BY ZIDOVUDINE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 38-38
TURNOVER OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING HIV-1 IN PATIENTS TREATED WITH 3TC
Authors: SCHUURMAN R VANLEEUWEN R NIJHUIS M KWOK S DEJONG D BOUCHER C
Citation: R. Schuurman et al., TURNOVER OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING HIV-1 IN PATIENTS TREATED WITH 3TC, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 39-39
THE RISE IN HIV-1 RNA LOAD DURING 3TC AZT COMBINATION THERAPY IS ASSOCIATED WITH THE SELECTION OF VIRUSES RESISTANT TO BOTH 3TC AND AZT/
Authors: NIJHUIS M DEJONG D VANLEEUWEN R DEGROOT T KEULEN W SCHUURMAN R BOUCHER C
Citation: M. Nijhuis et al., THE RISE IN HIV-1 RNA LOAD DURING 3TC AZT COMBINATION THERAPY IS ASSOCIATED WITH THE SELECTION OF VIRUSES RESISTANT TO BOTH 3TC AND AZT/, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 52-52
RAPID SELECTIVE OUTGROWTH OF A MINOR PREEXISTING DRUG-RESISTANT HIV-1SUBPOPULATION DURING SUBSEQUENT NEVIRAPINE TREATMENT
Authors: DEJONG MD SCHUURMAN R LANGE JMA BOUCHER CAB
Citation: Md. Dejong et al., RAPID SELECTIVE OUTGROWTH OF A MINOR PREEXISTING DRUG-RESISTANT HIV-1SUBPOPULATION DURING SUBSEQUENT NEVIRAPINE TREATMENT, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 81-81
A CONVENIENT APPROACH TO DETERMINING THE DRUG SUSCEPTIBILITY FROM SERUM HIV-1 RNA
Authors: BACK N KEULEN W NIJHUIS M VANBOMMEL T DEJONG D DEJONG M SCHUURMAN R BOUCHER C
Citation: N. Back et al., A CONVENIENT APPROACH TO DETERMINING THE DRUG SUSCEPTIBILITY FROM SERUM HIV-1 RNA, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 88-88
TRANSMISSION OF ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS FOLLOWING DELIBERATE INJECTION OF BLOOD FROM A PATIENT WITH AIDS - CHARACTERISTICS AND NATURAL-HISTORY OF THE VIRUS
Authors: VEENSTRA J SCHUURMAN R CORNELISSEN M VANTWOUT AB BOUCHER CAB SCHUITEMAKER H GOUDSMIT J COUTINHO RA
Citation: J. Veenstra et al., TRANSMISSION OF ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS FOLLOWING DELIBERATE INJECTION OF BLOOD FROM A PATIENT WITH AIDS - CHARACTERISTICS AND NATURAL-HISTORY OF THE VIRUS, Clinical infectious diseases, 21(3), 1995, pp. 556-560
SENSITIVE PROCEDURE FOR THE AMPLIFICATION OF HIV-1 RNA USING A COMBINED REVERSE-TRANSCRIPTION AND AMPLIFICATION REACTION
Authors: NIJHUIS M BOUCHER CAB SCHUURMAN R
Citation: M. Nijhuis et al., SENSITIVE PROCEDURE FOR THE AMPLIFICATION OF HIV-1 RNA USING A COMBINED REVERSE-TRANSCRIPTION AND AMPLIFICATION REACTION, BioTechniques, 19(2), 1995, pp. 178
RAPID CHANGES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LOAD AND APPEARANCE OF DRUG-RESISTANT VIRUS POPULATIONS IN PERSONS TREATED WITH LAMIVUDINE (3TC)
Authors: SCHUURMAN R NIJHUIS M VANLEEUWEN R SCHIPPER P DEJONG D COLLIS P DANNER SA MULDER J LOVEDAY C CHRISTOPHERSON C KWOK S SNINSKY J BOUCHER CAB
Citation: R. Schuurman et al., RAPID CHANGES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LOAD AND APPEARANCE OF DRUG-RESISTANT VIRUS POPULATIONS IN PERSONS TREATED WITH LAMIVUDINE (3TC), The Journal of infectious diseases, 171(6), 1995, pp. 1411-1419
ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: FRISSEN PHJ VANDERENDE ME TENNAPEL CHH WEIGEL HM SCHREIJ GS KAUFFMANN RH KOOPMANS PP HOEPELMAN AIM DEBOER JB WEVERLING GJ HAVERKAMP G DOWD P MIEDEMA F SCHUURMAN R BOUCHER CAB LANGE JMA
Citation: Phj. Frissen et al., ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 169(6), 1994, pp. 1351-1355
HIGH-LEVEL RESISTANCE TO (-) ENANTIOMERIC 2'-DEOXY-3'-THIACYTIDINE IN-VITRO IS DUE TO ONE AMINO-ACID SUBSTITUTION IN THE CATALYTIC SITE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
Authors: BOUCHER CAB CAMMACK N SCHIPPER P SCHUURMAN R ROUSE P WAINBERG MA CAMERON JM
Citation: Cab. Boucher et al., HIGH-LEVEL RESISTANCE TO (-) ENANTIOMERIC 2'-DEOXY-3'-THIACYTIDINE IN-VITRO IS DUE TO ONE AMINO-ACID SUBSTITUTION IN THE CATALYTIC SITE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2231-2234
Risultati: 1-24 |